| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.40B | 52.43B | 45.17B | 46.76B | 35.61B | 31.72B |
| Gross Profit | 14.81B | 16.75B | 14.49B | 14.84B | 12.16B | 10.40B |
| EBITDA | 3.39B | 5.17B | 3.52B | 3.76B | 2.51B | 1.99B |
| Net Income | 878.00M | 1.48B | 1.20B | 1.60B | 1.05B | 978.00M |
Balance Sheet | ||||||
| Total Assets | 73.14B | 71.81B | 73.43B | 64.40B | 58.51B | 48.16B |
| Cash, Cash Equivalents and Short-Term Investments | 12.14B | 12.78B | 12.34B | 14.61B | 11.68B | 11.59B |
| Total Debt | 35.38B | 31.51B | 35.42B | 26.85B | 24.34B | 16.82B |
| Total Liabilities | 48.68B | 46.00B | 48.76B | 40.24B | 35.95B | 26.54B |
| Stockholders Equity | 24.32B | 25.65B | 24.66B | 24.16B | 22.56B | 21.62B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.55B | -3.64B | 263.00M | -3.81B | 1.39B |
| Operating Cash Flow | 0.00 | 5.43B | 51.00M | 7.03B | 1.71B | 2.71B |
| Investing Cash Flow | 0.00 | -1.00B | -6.89B | -6.26B | -8.08B | -5.41B |
| Financing Cash Flow | 0.00 | -3.99B | 4.56B | 2.07B | 6.30B | 9.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥10.01B | 8.35 | ― | 4.19% | 16.05% | 23.13% | |
64 Neutral | ¥10.57B | -74.85 | ― | 0.78% | 11.35% | -39.33% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥10.09B | 47.55 | ― | ― | -7.33% | -85.66% | |
55 Neutral | ¥11.84B | 97.53 | ― | 0.74% | 6.53% | 12.30% | |
53 Neutral | ¥11.66B | 10.12 | ― | ― | 3.56% | ― | |
48 Neutral | ¥11.92B | 43.63 | ― | ― | 7.45% | -132.26% |